The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is asking its members to submit their feedback on a draft white paper on real-world evidence transparency.
The paper, “Improving Transparency in Non-Interventional Research for Hypothesis Testing – WHY, WHAT, and HOW: Considerations From the Real-World Evidence Transparency Initiative,” is part of a partnership with the International Society of Pharmacoepidemiology (ISPE), the Duke Margolis Center for Health Policy and the National Pharmaceutical Council.
The deadline for feedback is Oct. 3.
According to an email, the paper will be discussed at the upcoming ISPOR Summit, set for Oct. 11 in Baltimore, Maryland.
To learn more, click here.
